Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Sierra Oncology Inc (SRRA) Stock Forecast 2025 - AI Price Prediction & Analysis

Sierra Oncology Inc (SRRA) AI Stock Price Forecast & Investment Analysis

Sierra Oncology Inc Stock Price Chart and Technical Analysis

Loading Sierra Oncology Inc interactive price chart and technical analysis...

Sierra Oncology Inc (SRRA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Sierra Oncology Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Sierra Oncology Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Sierra Oncology Inc: Sierra Oncology Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

Sierra Oncology Inc (Stock Symbol: SRRA) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 69 professionals worldwide and operates under the strategic leadership of CEO Stephen Dilly.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Sierra Oncology Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Sierra Oncology Inc:

Market Capitalization: $1309 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -56.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Sierra Oncology Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Sierra Oncology Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Sierra Oncology Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Sierra Oncology Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Sierra Oncology Inc: Market positioning analysis based on available financial and operational metrics.

Sierra Oncology Inc strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Sierra Oncology Inc (SRRA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Sierra Oncology Inc stock analysis.

Loading Sierra Oncology Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Sierra Oncology Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Sierra Oncology Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Sierra Oncology Inc: With a P/E ratio of -8.13, the market sees the stock as potentially undervalued.

P/E Ratio -8.13x
P/B Ratio 5.00x
Market Cap $1309M
EPS $-6.76
Book Value/Share $10.99
FCF/Share $-5.62
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Sierra Oncology Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Sierra Oncology Inc: An ROE of -56.5% indicates room for improvement in shareholder value creation.

ROE -56.5%
ROA -52.6%
ROIC -55.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Sierra Oncology Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Sierra Oncology Inc: A current ratio of 21.27 indicates strong liquidity.

Current Ratio 21.27x
Quick Ratio 20.97x
D/E Ratio 0.02x
Financial Leverage 1.07x
Interest Coverage -1.5x
Working Capital $97M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Sierra Oncology Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Sierra Oncology Inc: Free cash flow of $-88M indicates cash challenges that need attention.

Operating Cash Flow $-88M
Free Cash Flow $-88M
CapEx/Sales 20.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Sierra Oncology Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Sierra Oncology Inc:

Receivables Turnover 0.6x
Fixed Assets Turnover 0.3x
Days Sales Outstanding 628 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Sierra Oncology Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Sierra Oncology Inc:

Income Statement ($ Millions)
Operating Income $-102M
Net Income $-76M
R&D Expense $71M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 99%
Cash & Short-term Investments 98%
Total Liabilities 7%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 24M

Latest Sierra Oncology Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Sierra Oncology Inc (SRRA) stock price and investment outlook.

, source: Business Insider

- MOMENTUM Phase 3 myelofibrosis clinical trial anticipated to launch in Q4 2019 - VANCOUVER, Nov. 4, 2019 /CNW/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on ...

, source: Insider Monkey

Investor Bill Ackman said the new omicron variant of the coronavirus could actually give U.S. stocks a boost if symptoms turn out to be less severe. The latest 13F reporting period has come and gone, ...

, source: Reuters

* SIERRA ONCOLOGY - ‍BELIEVES EXISTING CASH, CASH EQUIVALENTS TO BE SUFFICIENT TO FUND CURRENT OPERATING PLANS THROUGH ABOUT MID-2019 * SIERRA ONCOLOGY INC - CASH AND CASH EQUIVALENTS TOTALED $100.3 ...

, source: Benzinga.com

Vivo Opportunity Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, ...

Sierra Oncology Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Sierra Oncology Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Sierra Oncology Inc Stock Forecast

How accurate are Sierra Oncology Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for SRRA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Sierra Oncology Inc stock price forecasts?

Our analysis considers Sierra Oncology Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Sierra Oncology Inc a good investment in 2025?

Based on our AI analysis, Sierra Oncology Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Sierra Oncology Inc forecasts updated?

Sierra Oncology Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Sierra Oncology Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Sierra Oncology Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...